Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Gilliland

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Quinidine-induced dermatomyositis-like illnessW R Gilliland
Clinical Pharmacology and Therapeutics|November 15, 2007
Emerging biological therapies in systemic lupus erythematosusG R Mount, W R Gilliland
Annals of the Rheumatic Diseases|February 7, 2002
Prophylactic use of antibiotics and immunisations in patients with SLEW R Gilliland, G C Tsokos
Clinical Pharmacology and Therapeutics|March 22, 2012
Optimizing therapeutics: the next front in the war on rheumatoid arthritisJ D Edison, W R Gilliland
Clinical and Experimental Rheumatology|March 23, 2000
Klinefelter's syndrome and systemic lupus erythematosusW R Gilliland, M E Stashower
Clinical Pharmacology and Therapeutics|December 21, 2010
A curricular divide: basic pharmacology vs. clinical pharmacologyW R Gilliland, D M Waechter
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 14, 2006
The clinical spectrum of anti-insulin receptor antibodies and autoimmune diseaseW R Gilliland, G C Tsokos
Clinical Pharmacology and Therapeutics|August 25, 2011
Improving the use of allopurinol in chronic gout: monitoring oxypurinol levels to guide therapyM P Keith, W R Gilliland
Clinical Pharmacology and Therapeutics|August 23, 2012
Progress toward personalized treatment of rheumatoid arthritisM P Keith, J D Edison, W R Gilliland
Respiratory Medicine|April 28, 2000
Osseous disease in patients with pulmonary sarcoidosis and musculoskeletal symptomsA F Shorr, F T Murphy, W R Gilliland, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Quinidine-induced dermatomyositis-like illnessW R Gilliland
Clinical Pharmacology and Therapeutics|November 15, 2007
Emerging biological therapies in systemic lupus erythematosusG R Mount, W R Gilliland
Annals of the Rheumatic Diseases|February 7, 2002
Prophylactic use of antibiotics and immunisations in patients with SLEW R Gilliland, G C Tsokos
Clinical Pharmacology and Therapeutics|March 22, 2012
Optimizing therapeutics: the next front in the war on rheumatoid arthritisJ D Edison, W R Gilliland
Clinical and Experimental Rheumatology|March 23, 2000
Klinefelter's syndrome and systemic lupus erythematosusW R Gilliland, M E Stashower
Clinical Pharmacology and Therapeutics|December 21, 2010
A curricular divide: basic pharmacology vs. clinical pharmacologyW R Gilliland, D M Waechter
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 14, 2006
The clinical spectrum of anti-insulin receptor antibodies and autoimmune diseaseW R Gilliland, G C Tsokos
Clinical Pharmacology and Therapeutics|August 25, 2011
Improving the use of allopurinol in chronic gout: monitoring oxypurinol levels to guide therapyM P Keith, W R Gilliland
Clinical Pharmacology and Therapeutics|August 23, 2012
Progress toward personalized treatment of rheumatoid arthritisM P Keith, J D Edison, W R Gilliland
Respiratory Medicine|April 28, 2000
Osseous disease in patients with pulmonary sarcoidosis and musculoskeletal symptomsA F Shorr, F T Murphy, W R Gilliland, et al.
Pageof 2